BAM
RBOT

Belpointe Asset Management’s Vicarious Surgical RBOT Stock Holding History

Belpointe Asset Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-167
Closed -$10.1K – 3829
2022
Q4 		$10.1K Buy
+167
New +$15.5K ﹤0.01% 2615

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Belpointe Asset Management's RBOT Position: Q1 2023 in Review

Belpointe Asset Management sold out of Vicarious Surgical (RBOT) in Q1 2023, closing a stake of 167 shares — an estimated $10.1K sold.

Belpointe Asset Management first reported a position in RBOT in Q4 2022 and held it in 1 quarter. The position peaked at $10.1K in Q4 2022. 79 funds tracked by Wall St. Rank hold RBOT as of Q1 2023.

  • Belpointe Asset Management reported no remaining Vicarious Surgical position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 167 Vicarious Surgical shares in Q1 2023, an estimated $10.1K.
  • Belpointe Asset Management first reported a position in Vicarious Surgical in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's Vicarious Surgical position peaked at $10.1K in Q4 2022.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.